• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织肺肿瘤分类评估

Appraisal of the World Health Organization classification of lung tumours.

作者信息

Jacques J, Hill D P, Shier K J, Jindani A, Miller A B

出版信息

Can Med Assoc J. 1980 Apr 19;122(8):897-901.

PMID:7370873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1801636/
Abstract

The 1967 World Health Organization (WHO) classification of the histologic types of lung tumours has been examined in relation to 303 tumours of patients admitted to a national trial of the treatment of lung cancer. In 63 instances (20%) there was disagreement between the diagnoses of the local pathologist and the reference pathologist. The slides for these 63 tumours were reviewed by two other pathologists, and the slides for 60 tumours for which there was agreement between the local and reference pathologists were reviewed by one of the other pathologists. The main disagreement was in the diagnosis of epidermoid (squamous) tumours. It is apparent that many pathologists do not adhere to the strict criterion of the presence of keratinization or intercellular prickles or both for the diagnosis of epidermoid carcinoma. In addition, there was substantial variation in the use of subtypes within the WHO classification. Use of the revised classification proposed by the WHO would have removed a small amount of the variation from these findings but would not have affected the main discrepancy. Stricter attention to the definition of types is required for a uniform approach to the histologic classification of lung tumours.

摘要

对1967年世界卫生组织(WHO)的肺肿瘤组织学类型分类,在参与一项全国性肺癌治疗试验的303例患者的肿瘤中进行了检验。在63例(20%)病例中,当地病理学家与参考病理学家的诊断存在分歧。这63例肿瘤的切片由另外两位病理学家进行了复查,另外,当地和参考病理学家诊断一致的60例肿瘤的切片由其中一位病理学家进行了复查。主要分歧在于表皮样(鳞状)肿瘤的诊断。显然,许多病理学家在诊断表皮样癌时未遵循存在角化或细胞间棘突或两者皆有的严格标准。此外,在WHO分类中各亚型的使用存在很大差异。采用WHO提议的修订分类会减少这些结果中的少量差异,但不会影响主要差异。为实现肺肿瘤组织学分类的统一方法,需要更严格地关注类型的定义。

相似文献

1
Appraisal of the World Health Organization classification of lung tumours.世界卫生组织肺肿瘤分类评估
Can Med Assoc J. 1980 Apr 19;122(8):897-901.
2
The World Health Organization. Histological typing of lung tumours.世界卫生组织。肺肿瘤组织学分类。
Neoplasma. 1982;29(1):111-23.
3
Pathologic review of the Mayo Lung Project cancers [corrected]. Is there a case for misdiagnosis or overdiagnosis of lung carcinoma in the screened group?梅奥肺癌项目癌症的病理回顾[已修正]。筛查组中是否存在肺癌误诊或过度诊断的情况?
Cancer. 2002 Dec 1;95(11):2361-5. doi: 10.1002/cncr.10930.
4
Histological typing of lung cancer. Application of the World Health Organization classification to 479 cases.肺癌的组织学类型。世界卫生组织分类法在479例病例中的应用。
Acta Pathol Microbiol Scand A. 1976 Nov;84(6):529-37.
5
The World Health Organization's Histological Classification of Lung Tumors: a comparison of the first and second editions.世界卫生组织肺肿瘤组织学分类:第一版与第二版的比较。
Cancer Detect Prev. 1982;5(4):391-406.
6
[Classification and pathogenesis of lung carcinoma].[肺癌的分类与发病机制]
Rev Prat. 2003 Apr 1;53(7):714-20.
7
[Classification of broncho-pulmonary cancers (WHO 1999)].[支气管肺癌的分类(世界卫生组织,1999年)]
Rev Mal Respir. 2002 Sep;19(4):455-66.
8
[Histological typing of lung tumors. Second edition, 1981 (author's transl)].
Ann Pathol. 1981;1(3):177-91.
9
Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours).微乳头模式:一种独特的病理标志物,用于对具有混合细支气管肺泡和浸润性亚型的小周边肺腺癌(≤20mm)(野口氏C型肿瘤)中预后显著较差的肿瘤进行亚分类。
Histopathology. 2005 Jun;46(6):677-84. doi: 10.1111/j.1365-2559.2005.02126.x.
10
The challenge of classifying poorly differentiated tumours in the lung.
Histopathology. 2009 Jan;54(1):28-42. doi: 10.1111/j.1365-2559.2008.03181.x.

引用本文的文献

1
Discovery of Harmaline as a Potent Inhibitor of Sphingosine Kinase-1: A Chemopreventive Role in Lung Cancer.发现哈尔满碱是鞘氨醇激酶-1的强效抑制剂:在肺癌中的化学预防作用。
ACS Omega. 2020 Aug 20;5(34):21550-21560. doi: 10.1021/acsomega.0c02165. eCollection 2020 Sep 1.
2
The clinical significance of HPIP and the associated prognosis in cervical cancer.HPIP在宫颈癌中的临床意义及相关预后
Oncotarget. 2017 Jul 26;8(41):70262-70270. doi: 10.18632/oncotarget.19607. eCollection 2017 Sep 19.
3
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.SIRT6的上调预示着非小细胞肺癌的预后不良,并通过ERK1/2/MMP9途径促进其转移。
Oncotarget. 2016 Jun 28;7(26):40377-40386. doi: 10.18632/oncotarget.9750.
4
NDRG1 attenuates epithelial-mesenchymal transition of nasopharyngeal cancer cells via blocking Smad2 signaling.NDRG1通过阻断Smad2信号通路减弱鼻咽癌细胞的上皮-间质转化。
Biochim Biophys Acta. 2015 Sep;1852(9):1876-86. doi: 10.1016/j.bbadis.2015.06.009. Epub 2015 Jun 10.
5
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma.CUEDC2下调与肺腺癌的肿瘤生长及不良预后相关。
Oncotarget. 2015 Aug 21;6(24):20685-96. doi: 10.18632/oncotarget.3930.
6
Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.含胶原蛋白三螺旋重复序列1(Cthrc1)是吸烟非小细胞肺癌的独立预后生物标志物。
Tumour Biol. 2014 Nov;35(11):11677-83. doi: 10.1007/s13277-014-2449-0. Epub 2014 Aug 21.
7
Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.M3 型毒蕈碱型乙酰胆碱受体过表达促进非小细胞肺癌转移并预示不良预后。
J Thorac Oncol. 2014 Feb;9(2):170-8. doi: 10.1097/JTO.0000000000000066.

本文引用的文献

1
APPLICATION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF LUNG CARCINOMA TO BIOPSY MATERIAL.世界卫生组织肺癌分类在活检材料中的应用。
Ann Thorac Surg. 1965 Jan;1:33-49. doi: 10.1016/s0003-4975(10)66719-7.
2
Observer variability in the histopathologic diagnosis of lung cancer.肺癌组织病理学诊断中的观察者变异性。
Am Rev Respir Dis. 1970 May;101(5):671-84. doi: 10.1164/arrd.1970.101.5.671.
3
An attempt to use the WHO typing in the histological classification of lung carcinomas.
Acta Pathol Microbiol Scand A. 1974 Nov;82(6):783-90. doi: 10.1111/j.1699-0463.1974.tb00406.x.
4
A reappraisal of histopathology in lung cancer and correlation of cell types with antecedent cigarette smoking.
Am Rev Respir Dis. 1973 May;107(5):790-7. doi: 10.1164/arrd.1973.107.5.790.
5
Controversies in WHO tumour classification.世界卫生组织肿瘤分类中的争议
Br Med J. 1978 Oct 28;2(6146):1203-4. doi: 10.1136/bmj.2.6146.1203.
6
Bronchiolo-alveolar carcinoma: a Clara cell tumor?细支气管肺泡癌:一种克拉拉细胞肿瘤?
Cancer. 1977 Nov;40(5):2171-80. doi: 10.1002/1097-0142(197711)40:5<2171::aid-cncr2820400527>3.0.co;2-f.
7
Histological typing of lung cancer. Application of the World Health Organization classification to 479 cases.肺癌的组织学类型。世界卫生组织分类法在479例病例中的应用。
Acta Pathol Microbiol Scand A. 1976 Nov;84(6):529-37.
8
An assessment of the World Health Organization classification of the histologic typing of lung tumors applied to biopsy and resected material.
Cancer. 1975 Feb;35(2):399-405. doi: 10.1002/1097-0142(197502)35:2<399::aid-cncr2820350215>3.0.co;2-v.